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INTRODUCTION:  We  report  a case  of  malignant  melanoma  arising  in  medullary  thyroid  carcinoma  that
has not  yet  been  described.
PRESENTATION  OF  CASE:  A  66-year-old  woman  presented  with  a mass  in her thyroid.  The  resected  mass
was  black  in  color,  and was  composed  of  a  mixture  of classic  medullary  thyroid  carcinoma  and  pleomor-
phic atypical  cells  containing  melanin  pigments.  The  pleomorphic  atypical  cells  were  morphologically
consistent  with  malignant  melanoma,  and  expressed  Melan-A,  HMB-45,  and  S-100  protein  as determined
by  immunohistochemistry.  Some  of these  cells  were  also  positive  for  calcitonin  and  chromogranin  A.
Although  the  malignant  melanoma  metastasized  to  the lymph  nodes,  the  patient  remained  free  from
local  recurrence  and  distant  metastasis  and  the primary  malignant  melanoma  lesion  was  not  identiﬁedelanin pigment for up  to 11 years  after  the thyroidectomy.
DISCUSSION:  11 melanin-producing  MTC  cases  have been  reported  to  date.  In the reported  cases,  the term
“malignant  melanoma”  was  not  used,  likely  because  the melanin-containing  carcinoma  cells  were not
morphologically  consistent  with  malignant  melanoma,  but  with  medullary  carcinoma.
CONCLUSION:  Malignant  melanoma  arising  in MTC  may  have  a favorable  prognosis.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Medullary thyroid carcinoma (MTC) is a malignant tumor of the
hyroid that exhibits C-cell differentiation. Microscopically, MTC
an exhibit divergent growth patterns and cytologic features, and
everal subtypes have been proposed, such as spindle cell, papillary,
ncocytic, follicular, clear cell, giant cell, and paraganglioma-like
ariants [1]. MTC  may  produce melanin pigments, which is referred
o as melanin-producing MTC  [2–10]. The amount of melanin pig-
ents ranges from microscopic foci to massive production. MTC
hat produces massive amounts of melanin is extremely rare.
We encountered a case of melanin-producing MTC  that con-
ained pleomorphic atypical cells expressing markers of both
TC  (calcitonin) and melanoma. The pleomorphic atypical cells
ere morphologically and immunohistochemically consistent with
alignant melanoma. To the best of our knowledge, such a case has
∗ Corresponding author at: Department of Diagnostic Pathology and Cytol-
gy Kuma Hospital 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe 650-0011, Japan.
ax: +81 78 371 3645.
E-mail address: mhirokawa@kuma-h.or.jp (M.  Hirokawa).
1 Department of Surgery, Uchinomi Hospital, at the time of surgery for the present
atient.
ttp://dx.doi.org/10.1016/j.ijscr.2016.01.029
210-2612/© 2016 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
not yet been reported. Herein, we  report the ﬁrst case of malignant
melanoma arising in MTC.
2. Presentation of case
A 66-year-old woman  presented with an anterior neck mass
that had persisted for one year. When the mass began to gradually
increase in size, she visited Uchinomi Hospital for an evaluation.
She had no hoarseness. She did not have a family history of MTC.
On physical examination, the mass was located in the left lobe
of the thyroid and was  ovular, soft, and movable, with slightly
irregular margins. Enlarged lymph nodes were not palpable in the
neck region. Laboratory results, including those from a thyroid hor-
mone test, were within normal limits. A chest radiograph revealed
a deviation to the right of the trachea. No abnormal calciﬁcation
was observed in the thyroid, and there was no evidence indicating
metastatic lesions in the lung. Fine needle aspiration cytology and
ultrasound examination were not performed, because it was not
standard in 1984, when the patient was evaluated.A partial thyroidectomy was  planned and took place under gen-
eral anesthesia. During the surgery, we noted many small black
lymph nodes measuring 3–7 mm in the central and left lateral neck
compartments. Metastatic melanoma was suspected based on the
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. H&E stain of the thyroid mass. Melanoma cells were considerably pleomor-
phic and contained various amounts of brown pigment.
Fig. 3. H&E stain of the thyroid mass. Medullary carcinoma cells were visible in the
subcapsular area.ig. 1. Cut surface of the left thyroid mass (dorsal view). The mass is well demarcated
nd black in color.
ntense black color of the cut surfaces of the thyroid tumor and
ymph nodes. No dermal lesions suggesting malignant melanoma
ere observed on the patient’s head, face, hands, or feet. The
natomical distribution of the black lymph nodes was  consistent
ith that of metastatic nodes from thyroid cancer. We  therefore
uspected melanin-producing MTC, and performed total thyroidec-
omy with a left modiﬁed radical neck dissection. An extensive
ost-surgery examination, including the skin, nasopharynx, oral
ucosa, upper gastrointestinal tract, and gynecologic organs, was
erformed by the specialists in the respective ﬁelds, but a primary
ite of the melanoma could not be identiﬁed. Serum calcitonin
nd carcinoembryonic antigen (CEA) levels at the time of surgery
ere 960 pg/mL (normal value: less than 100 pg/mL) and 6.1 ng/mL
normal value: less than 2.5 ng/mL), respectively. One month after
he thyroidectomy, serum calcitonin levels had returned to normal
25 pg/mL). The patient remained free from local recurrence and
istant metastasis and the primary malignant melanoma lesion was
ot identiﬁed for up to 11 years after the thyroidectomy. Addition-
lly, serum calcitonin level remained within normal ranges.
.1. Pathological ﬁndings
Grossly, a well-demarcated mass measuring 4.8 × 3.0 × 3.0 cm
as located in the left lobe of the thyroid. The cut surface was  solid
nd intensely black in color (Fig. 1). Microscopically, the mass was
ell demarcated by a discontinuous ﬁbrous capsule and composed
f two distinct atypical cells. One cell type was large, round or pleo-
orphic, occupied a majority of the mass, and exhibited an alveolar
r solid growth pattern (Fig. 2). The nests of cells were separated
y a thin ﬁbrovascular stroma. These atypical cells were discohe-
ive and tended to be individually separated at the inner part of the
ests. The cytoplasm was abundant as indicated by a low nucleus
o cytoplasm (N/C) ratio, and the cell borders were distinct. Most
f these atypical cells contained brown pigments, the quantity of
hich varied from scant to abundant. The brown pigments were
ositive by Fontana-Masson stain, negative by both Berlin blue and
AS stains, and perfectly bleached by 0.25% potassium perman-
anate and 2% oxalic acid, suggesting that they were composed of
elanin. Despite the low N/C ratio, the nuclei were large, eccentri-
ally located, and had prominent large nucleoli. Some of these cells
xhibited rhabdoid features. Additionally, mitotic ﬁgures, multinu-
leated giant cells, and necrosis were detected. In all, the features of
hese atypical cells were microscopically consistent with malignant
elanoma.
The second type of atypical cell found in the tumor was  focally
bserved, especially in the subcapsular area (Fig. 3). These cells
ere small with a round or spindled shape. N/C was  high, and the
uclei were bland and round or short spindled in shape. In contrast
o the ﬁrst type of atypical cell, their cell border was indistinct and
hey did not contain brown pigments. Amyloid materials that wereconﬁrmed by Congo-red stain were present in the stroma. The ﬁnd-
ings were consistent with classic MTC. Malignant melanoma and
MTC  were intimately intermingled without a front formation. The
malignant melanoma had metastasized to 19 cervical lymph nodes
(lt. III: 3/13, lt. IV: 10/25, lt. V: 1/6, and VI: 5/5), but metastasis of
the MTC  was not observed.
Results of the immunohistochemical analysis are summarized
in Table 1. The large pleomorphic atypical cells (melanoma cells)
expressed Melan-A (Fig. 4A), HMB-45 (Fig. 4B), and S-100 protein
as determined by immunohistochemistry, and were focally posi-
tive for calcitonin (Fig. 5A), chromogranin A, CEA and cytokeratin
7. Speciﬁcally, the melanoma cells that contained scant melanin
pigments or were located near the stroma tended to react with
the antibodies. The melanoma cells were negative for PAX8, TTF-1,
cytokeratin MNF116, cytokeratin 20, and EMA. The small atypi-
cal cells (MTC cells) were diffusely positive for calcitonin (Fig. 5B),
chromogranin A, and CEA, and negative for Melan-A, HMB-45, S-
100 protein, calcitonin, chromogranin A, CEA, and cytokeratin 7.
Ki-67 labeling indices of the malignant melanoma and MTC  com-
ponents were more than 40% and less than 1%, respectively.
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Table  1
Results of the immunohistochemical analysis.
Antibody (Vendor, Clone, Dilution) Medullary carcinoma Malignant melanoma
Calcitonin (Dako, polyclonal, 1:10) + + (Focal)
Chromogranin A (Dako, DAK-A3, 1:400) + + (Focal)
CEA  (Histoﬁne, COL-1, 1:4) + + (Focal)
Thyroglobulin (Dako, polyclonal, 1:5) − −
PAX  8 (Protein Tech Group, polyclonal, 1:200) + (Focal) −
TTF-1 (Dako Cytomation, 8G7G3/1, 1:100) + (Focal) −
Cytokeratin MNF116 (Abcam, MNF116, 1:100) + −
Cytokeratin 7 (Dako, OV-TL 12/30, 1:50) + + (Focal)
Cytokeratin 20 (Dako, Ks20, 1:50) − −
EMA  (Dako, E29, 1:50) − −
Melan-A (Novocastra A103, 1:25) − +
HMB-45 (Dako, HMB45, 1:50) − +
S-100 protein (Dako Cytomation, polyclonal, 1:2) − +
Vimentin (Nichirei, V9, predilution) + +
Ki-67  (Dako, MIB-1, 1:200) Less than 1% More than 60%
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Fig. 5. Immunohistochemical detection of calcitonin. Melanoma cells were only
focally positive for calcitonin (A), whereas, medullary carcinoma cells were diffuselyig. 4. Immunohistochemical detection of Melan A (A) and HMB-45 (B). Melanoma
ells were positive for Melan A (A) and HMB-45 (B).
. Discussion
MTC  is a malignant tumor that exhibits C-cell differentiation
1], a phenotype typically determined by immunohistochemical
taining using an antibody against calcitonin. Additionally, MTC
xpresses CEA and neuroendocrine markers including chromo-
ranin A. The small-sized atypical cells observed in the current
ase morphologically resembled classic MTC, and this diagnosis
as conﬁrmed using immunohistochemistry to detect calcitonin,
EA, and chromogranin A expression.positive (B).
MTC  can show multidirectional differentiation, resulting in a
number of subtypes, such as mucin-producing MTC, MTC  with
squamous differentiation, and melanin-producing MTC  [1], the
latter of which is extremely rare. In the current case, the large pleo-
morphic atypical cells contained melanin pigments, as conﬁrmed
by Fontana-Masson staining and bleaching method. Additionally,
some of these cells were immunohistochemically positive for calci-
tonin, CEA, and chromogranin A expression. Therefore, the current
case was consistent with melanin-producing MTC.
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To the best of our knowledge, 11 melanin-producing MTC  cases
ave been reported to date [2–10], with variable microscopic ﬁnd-
ngs. In the published reports, carcinoma cells were described as
lassic, spindled, or pleomorphic. Melanin production also var-
ed from scant to abundant. In some cases, melanin-producing
ells were localized to dendritic or sustentacular cells [5,6]. The
elanocytic differentiation was conﬁrmed by the presence of
elanin pigments or by the expression of HMB-45 or S-100 pro-
ein. In the reported cases, the term “malignant melanoma” was
ot used, likely because the melanin-containing carcinoma cells
ere not morphologically consistent with malignant melanoma,
ut with medullary carcinoma.
In the current case, the majority of the tumor was occupied
y large pleomorphic cells with massive melanin pigments. These
typical cells were considerably pleomorphic and were similar to
naplastic thyroid carcinoma (ATC) or the anaplastic variant of MTC,
ith the exception of the presence of melanin pigments. In 1980,
endelsohn et al. ﬁrst proposed an anaplastic variant of MTC  [11].
ccording to the report, most of the carcinoma cells retained C-
ell properties as determined by immunohistochemistry. However,
ost of the large pleomorphic cells observed in the current case
ere negative for the C-cell markers, including calcitonin, chro-
ogranin A, and CEA, and were positive for melanoma markers
ncluding Melan-A, HMB-45, and S-100 protein. In addition, the
ells were negative for PAX8, which is known to be expressed in
TC  and ATC [12]. In all, these data strongly suggest that the large
leomorphic cells are malignant melanoma. Malignant melanoma
etastasizing to the thyroid is not rare, but the presence of large
leomorphic carcinoma cells expressing both MTC  and melanoma
arkers suggests that this is not the case. Additionally, we  could not
ocate the primary malignant melanoma lesion despite extensive
xamination of the other organs. Consequently, we concluded that
he current case is one of malignant melanoma arising in melanin-
roducing MTC, which has not yet been reported.
MTC  is a type of neuroendocrine carcinoma that produces hor-
ones or regulatory proteins. Malignant melanoma is a malignant
umor arising from melanocytes derived from a structure in the
uman embryo called the neural crest. Although neuroendocrine
arcinoma and malignant melanoma have different embryologi-
al origins, carcinomas with both neuroendocrine and melanocytic
ifferentiations have been reported in the retroperitoneum [13],
drenal gland [14], thymus [15], skin [16], nasal mucosa [16], and
ung [17]. Similarly, in the current case, there were three types
f carcinoma cells: classic MTC  cells, carcinoma cells having both
-cell and melanocytic characteristics (melanin-producing MTC
ells), and malignant melanoma cells without C-cell characteristics.
t is postulated that the tumor arose from polyclonal evolution of
ommon precursor cells with the ability to produce both hormones
nd melanin, or that MTC  transformed into a more aggressive can-
er with the ability to produce melanin.
The long-term prognosis of the current case is very interest-
ng. Considering the extensive pleomorphism, high Ki-67 labeling
ndex, presence of extensive nodal metastasis, and known outcome
f malignant melanoma, the tumor described in the current case
hould be highly malignant. Nevertheless, no detectable recurrence
r distant metastasis occurred up to 11 years post-surgery. The
rognosis of the anaplastic variant of MTC  composed of large pleo-
orphic cells resembling ATC is signiﬁcantly better than that of
TC [11]. Similarly, malignant melanoma arising in MTC  may have
 favorable prognosis.. Conclusion
We  report a case of malignant melanoma arising in melanin-
roducing MTC  that has not previously been described. ThePEN  ACCESS
rgery Case Reports 20 (2016) 118–122 121
diagnosis of malignant melanoma was conﬁrmed by classic his-
tologic ﬁndings and immunohistochemical results. Contrary to
expectation, malignant melanoma arising in MTC  may have a favor-
able prognosis.
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